Serial Number | 79209028 |
Word Mark | MULTIBODY |
Filing Date | Friday, October 21, 2016 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, November 8, 2024 |
Registration Number | 5450600 |
Registration Date | Tuesday, April 24, 2018 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 6, 2018 |
Goods and Services | Treatment and transformation of materials, namely, custom manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing in the field of chemicals, biologicals, antibodies and antibody fragments; services for the custom manufacture of therapies using antibodies and antibody fragments |
Goods and Services | Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; veterinary preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; therapeutic preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes; antibodies, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibody fragments being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; monoclonal antibodies for therapeutic purposes, namely, therapeutic agents for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for medical and veterinary diagnostics; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for use in the discovery, preclinical and clinical development of therapeutic products; antibodies and antibody fragments, being pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases, for use in the manufacture of therapeutic products |
Pseudo Mark | MULTI BODY |
Goods and Services | Chemicals used in industry and science; chemicals for laboratory research purposes; monoclonal antibodies and antibody fragments for scientific and laboratory use; monoclonal antibodies and antibody fragments for scientific research purposes; monoclonal antibody reagents for scientific and laboratory use; monoclonal antibodies and antibody fragments for scientific research purposes for use in the manufacture of therapeutic products |
Goods and Services | Scientific and technological services, namely, scientific research, analysis and testing and research and design in the field of chemicals, biologicals, antibodies and antibody fragments; scientific laboratory services relating to antibodies and antibody fragments; research and development in the field of antibodies and antibody fragments; medical research laboratory services relating to antibodies and antibody fragments; engineering of antibodies and antibody fragments; scientific research relating to the discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto, namely, consulting in the field of antibody and antibody fragment design |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 8, 2024 |
Primary Code | 040 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 8, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 8, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, November 8, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Crescendo Biologics Limited |
Party Type | 30 - Original Registrant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | Cambridge, Cambridgeshire CB22 3AT GB |
Party Name | Crescendo Biologics Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | Cambridge, Cambridgeshire CB22 3AT GB |
Party Name | Crescendo Biologics Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 24 - NOT AVAILABLE |
Address | Cambridge, Cambridgeshire CB22 3AT GB |
Event Date | Event Description |
Thursday, June 1, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, June 9, 2017 | APPLICATION FILING RECEIPT MAILED |
Thursday, June 22, 2017 | REFUSAL PROCESSED BY MPU |
Friday, June 23, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Thursday, December 7, 2017 | NEW REPRESENTATIVE AT IB RECEIVED |
Tuesday, December 12, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, June 5, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, June 6, 2017 | ASSIGNED TO EXAMINER |
Tuesday, June 13, 2017 | NON-FINAL ACTION WRITTEN |
Wednesday, June 14, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Friday, July 14, 2017 | REFUSAL PROCESSED BY IB |
Tuesday, December 19, 2017 | ASSIGNED TO LIE |
Thursday, December 21, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, December 21, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, December 28, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, January 17, 2018 | NOTICE OF PUBLICATION |
Thursday, February 1, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, February 6, 2018 | PUBLISHED FOR OPPOSITION |
Tuesday, April 24, 2018 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, July 24, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Thursday, February 1, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, September 7, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Monday, April 24, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Friday, October 27, 2023 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
Friday, November 8, 2024 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
Friday, November 8, 2024 | CANCELLED SECTION 71 |
Saturday, August 19, 2023 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
Thursday, August 9, 2018 | FINAL DISPOSITION PROCESSED |
Thursday, August 9, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |